Report - ADO-Studientreffen Melanom Adjuvant/Neoadjuvant · ZDO EORTC-18081 Adjuvant Pegylated-Interferon-alpha2b (SylatronTM) for 2 Years Versus Observation in Patients With an Ulcerated

Please pass captcha verification before submit form